XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue $ 1,006,564 $ 875,363
Cost of revenue 515,874 450,292
Gross profit 490,690 425,071
Operating expenses:    
Research and development 238,595 240,611
Sales and marketing 259,885 287,906
General and administrative 112,568 114,362
Restructuring costs 121,942 0
Impairment of long-lived assets 21,784 0
Total operating expenses 754,774 642,879
Loss from operations (264,084) (217,808)
Other expenses, net:    
Share of losses from equity method investment (30,419) 0
Impairment of strategic investments (46,154) 0
Other income (expenses), net 8,985 (6,677)
Total other expenses, net (67,588) (6,677)
Loss before (provision for) benefit from income taxes (331,672) (224,485)
(Provision for) benefit from income taxes (10,467) 2,858
Net loss attributable to common stockholders $ (342,139) $ (221,627)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (1.84) $ (1.23)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (1.84) $ (1.23)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 186,403,349 180,898,713
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 186,403,349 180,898,713